disopyramide has been researched along with isoproterenol in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (46.67) | 18.7374 |
1990's | 8 (26.67) | 18.2507 |
2000's | 5 (16.67) | 29.6817 |
2010's | 3 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hayler, AM; Holt, DW; Medd, RK; O'Keeffe, B | 2 |
Hayler, AM; Holt, DW; Medd, RK; O'Keeffe, BD | 1 |
Barrillon, A; Grand, A | 1 |
Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D | 1 |
Emori, T; Kurita, T; Ohe, T; Shimizu, W; Shimomura, K | 1 |
Elliott, L; Grubb, BP; Hahn, H; Temesy-Armos, P | 1 |
Benditt, DG; Buetikofer, J; Dunnigan, A; Gornick, C; Milstein, S; Reyes, WJ | 1 |
Mathur, PP | 1 |
Kerr, CR; Levick, CE; Mizgala, HF | 1 |
Silberschmidt, U | 1 |
Ashkenazi, J; Feigl, D; Schwarzmann, H | 1 |
Gottlieb, S; Keren, A; Stern, S; Tzivoni, D | 1 |
Marshall, RJ; Muir, AW; Winslow, E | 1 |
Benhorin, J; Corcos, P; Golhman, JM; Keren, A; Stern, S; Tzivoni, D | 1 |
Cook, G; Hayler, AM; Helliwell, M; Holt, DW; Marshall, CB; O'Keeffe, B | 1 |
Adler, SW; Fuenzalida, CE; Kelly, PA; Mann, DE; Reiter, MJ | 1 |
Centurion, OA; Fukatani, M; Hashiba, K; Isomoto, S; Kaibara, M; Konoe, A; Shimizu, A; Tanigawa, M; Yano, K | 1 |
Eichler, HG; Gouya, G; Schmetterer, L; Wolzt, M; Zanaschka, G | 1 |
Chemtob, S; Deng, XF; Mulay, S; Varma, DR | 1 |
Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Matsuo, K; Shimizu, W; Suyama, K; Taguchi, A; Takagi, M; Tanabe, Y | 1 |
SEKIYA, A; VAUGHANWILLIAMS, EM | 1 |
Elesber, A; Holmes, DR; Nishimura, RA; Ommen, SR; Rihal, CS; Schaff, HV | 1 |
3 review(s) available for disopyramide and isoproterenol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Incompatibility and interference of the major cardiologic drugs. Their undesirable effects].
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antihypertensive Agents; Bradycardia; Cardiac Glycosides; Digitalis Glycosides; Disopyramide; Drug Interactions; Drug Synergism; Humans; Hypertension; Hypokalemia; Isoproterenol; Lidocaine; Monoamine Oxidase Inhibitors; Ouabain; Phenytoin; Prenylamine; Procainamide; Quinidine | 1976 |
[Disopyramide poisoning].
Topics: Acid-Base Equilibrium; Arrhythmias, Cardiac; Disopyramide; Heart Ventricles; Hemoperfusion; Humans; Isoproterenol; Potassium; Pyridines; Shock, Cardiogenic; Ventricular Fibrillation | 1981 |
2 trial(s) available for disopyramide and isoproterenol
Article | Year |
---|---|
Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Disopyramide; Female; Humans; Isoproterenol; Male; Methods; Middle Aged; Posture; Recurrence; Scopolamine; Syncope | 1991 |
Is the ECG measure RSh a promising technique for detecting class I antiarrhythmic drug action in men?
Topics: Adenosine; Adult; Ajmaline; Anti-Arrhythmia Agents; Atropine; Disopyramide; Electrocardiography; Humans; Injections, Intravenous; Isoproterenol; Male; Norepinephrine; Propranolol; Reproducibility of Results; Sodium Channel Blockers; Verapamil | 1995 |
25 other study(ies) available for disopyramide and isoproterenol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac Glycosides; Cardiovascular Diseases; Digitalis Glycosides; Disopyramide; Diuretics; Dose-Response Relationship, Drug; Humans; Isoproterenol; Lidocaine; Myocardial Contraction; Propranolol; Quinidine | 1978 |
Treatment of disopyramide overdosage.
Topics: Antidotes; Bradycardia; Disopyramide; Humans; Isoproterenol; Pyridines; Seizures | 1979 |
Experimental disopyramide poisoning: treatment by cardiovascular support and with charcoal hemoperfusion.
Topics: Animals; Cardiac Output; Charcoal; Disopyramide; Dogs; Dopamine; Glucagon; Hemodynamics; Hemoperfusion; Isoproterenol; Pyridines; Time Factors | 1979 |
Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs.
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Dopamine; Electrocardiography; Glucagon; Heart Arrest; Heart Failure; Hemodynamics; Isoproterenol; Pyridines | 1979 |
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Head; Humans; Isoproterenol; Male; Monitoring, Physiologic; Posture; Prospective Studies; Recurrence; Scopolamine; Syncope | 1992 |
Induction of TU abnormalities in patients with torsades de pointes.
Topics: Action Potentials; Adolescent; Aged; Disopyramide; Electrocardiography; Female; Heart Conduction System; Humans; Infusions, Intravenous; Isoproterenol; Male; Middle Aged; Torsades de Pointes | 1992 |
Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
Topics: Adult; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Posture; Syncope; Time Factors | 1990 |
Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiomegaly; Catheterization; Coronary Circulation; Disopyramide; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Femoral Artery; Femoral Vein; Heart; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Norepinephrine; Pyridines; Quinidine; Tyramine | 1972 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Humans; Isoproterenol; Pacemaker, Artificial; Phenytoin; Procainamide; Tachycardia | 1984 |
[Atypical ventricular tachycardia due to disopyramide].
Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Pyridines; Quinidine; Tachycardia | 1982 |
Disopyramide-induced Torsade de Pointes.
Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Middle Aged; Pyridines; Tachycardia | 1981 |
Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.
Topics: Androstanols; Angiotensin II; Animals; Arrhythmias, Cardiac; Atropine; Catecholamines; Coronary Vessels; Disease Models, Animal; Disopyramide; Epinephrine; Isoproterenol; Norepinephrine; Phenylephrine; Practolol; Rats; Ventricular Fibrillation | 1981 |
Ventricular pacing in atypical ventricular tachycardia.
Topics: Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Humans; Isoproterenol; Male; Quinidine; Tachycardia | 1981 |
Successful management of serious disopyramide poisoning.
Topics: Adult; Disopyramide; Hemoperfusion; Humans; Isoproterenol; Male; Potassium; Pyridines | 1980 |
Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing.
Topics: Adolescent; Adult; Aged; Blood Pressure; Disopyramide; Female; Head; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Posture; Supine Position; Syncope | 1994 |
Mechanism of the suppression of repetitive atrial firing by isoproterenol--comparison with disopyramide.
Topics: Adult; Atrial Fibrillation; Atrial Function; Disopyramide; Electric Stimulation; Electrocardiography; Heart Atria; Heart Conduction System; Humans; Isoproterenol; Middle Aged | 1994 |
Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
Topics: Animals; Anti-Arrhythmia Agents; Atropine; Bupivacaine; Catecholamines; Dimethylphenylpiperazinium Iodide; Disopyramide; Heart Atria; Isoproterenol; Male; Myocardial Contraction; Propranolol; Quinidine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stimulation, Chemical | 1997 |
Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms.
Topics: Action Potentials; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Bundle-Branch Block; Diagnosis, Differential; Disopyramide; Humans; Infusions, Intravenous; Isoproterenol; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ventricular Fibrillation | 2000 |
THE EFFECTS OF PRONETHALOL, DICHLOROISOPRENALINE AND DISOPYRAMIDE ON THE TOXICITY TO THE HEART OF OUABAIN AND ANAESTHETICS.
Topics: Anesthetics; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Brugada Syndrome; Cardiac Complexes, Premature; Cardiac Conduction System Disease; Disopyramide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Isoproterenol; Ouabain; Pharmacology; Research; Strophanthins; Sympatholytics; Toxicology | 1963 |
Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Catheterization; Cardiac Surgical Procedures; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Disopyramide; Ethanol; Female; Heart Septum; Humans; Isoproterenol; Male; Middle Aged; Retrospective Studies; Solvents; Ventricular Outflow Obstruction | 2008 |